Technology | April 08, 2008

Mediware Medication Management Software Features Safety Upgrades

The newest version of Mediware's medication management software suite reportedly offers enhanced data integration and functional improvements for tracking of medication orders, administrations and histories.

Version 3.0 is said to provide functional improvements to each application in order to streamline communication between clinicians throughout the hospital. It also includes integration points designed to ease collaboration with other systems within the client�s environment.

Specific product enhancements for the suite include updated safe medication practices information to meet JCAHO inpatient safety standards, improved medication profiles and clinical information, increased alerts and notifications and upgraded screens and displays.

Mediware's suite combines the company's MediREC, WORx, MediMA and MediCOE applications. MediREC includes automated medication reconciliation that electronically captures home medications and provides longitudinal medication records to support reconciliation throughout a patient's stay. WORx is a pharmacy management solution for inpatient and outpatient settings, including inventory management, online adjudication and Web-based access for remote users. MediMAR includes bedside administration and documentation tools designed to ensure the correct medications are delivered to the right patient at the right time. MediCOE�s electronic clinician ordering streamlines orders associated with poor handwriting or patient misidentification.

April 2003


Related Content

News | Pharmaceuticals

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

Home July 10, 2024
Home
News | Pharmaceuticals

June 5, 2024 — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis of clinical data ...

Home June 05, 2024
Home
News | Pharmaceuticals

May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA ...

Home May 24, 2024
Home
News | Pharmaceuticals

May 6, 2024 — Tenax Therapeutics, Inc., a Phase 3, development-stage pharmaceutical company focused on identifying ...

Home May 06, 2024
Home
News | Pharmaceuticals

February 16, 2024 — AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company focusing on ...

Home February 16, 2024
Home
News | Pharmaceuticals

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti ...

Home January 25, 2024
Home
News | Pharmaceuticals

November 21, 2023 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home November 21, 2023
Home
Feature | Pharmaceuticals | By Christine Book

In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor ...

Home October 25, 2023
Home
Videos | Pharmaceuticals

In this third and final segment in DAIC’s “One on One” series with Dr. Christine Seidman, learn what’s on the horizon at ...

Home September 26, 2023
Home
Subscribe Now